Pharmaceuticals

Strengthening our R&D capabilities, a cornerstone of our pharmaceutical business

Since 1987, we have been expanding steadily. We opened our Central Pharmaceutical Research Institute in Osaka in 1993, and established a clinical development base outside Japan in 2000 with the addition of our development function to Akros Pharma Inc., our US subsidiary. We focus mainly on the fields of Cardiovascular, Renal and Metabolism (CVRM); Immunology; and Neuroscience.

We are accelerating development in order to provide patients with our drugs as soon as possible. We are enhancing our research and development pipeline, exploring opportunities for strategic in- or out-licensing and strengthening collaboration with our license partners.

• Clinical development of pharmaceuticals

We incorporated Torii Pharmaceutical as a group company in 1998 to strengthen our domestic pharmaceutical business. To maximize synergies, JT now concentrates on R&D activities while Torii Pharmaceutical is in charge of manufacturing, sales and promotion.

* We stopped manufacturing at our Group's factories during FY2020, so all manufacturing processes for pharmaceutical products have been outsourced

At Torii Pharmaceutical, highly-trained medical representatives (MRs) play a crucial role for successful sales and promotion by providing medical and scientific knowledge to physicians, pharmacists, and other medical staff, aiming to not only help patients to regain health but also to promote better health for all people.

• About Torii Pharmaceutical Co., Ltd.